Depomed (DEPO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free DEPO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVulvodynia Treatment Market Size and Growth Analysis | Future Trends Analysis and Revenue Status 2023-2030finance.yahoo.com - October 30 at 10:23 AMHorizon Pharma (HZNP) Stock Sinks After DepoMed Rejects Unsolicited $3 Billion Bidthestreet.com - August 29 at 1:18 AMWhy DepoMed (DEPO) Stock Is Gaining Todaythestreet.com - August 13 at 4:04 AMSurge in Chronic Disorders Fuels Expansion of Global Tapentadol Market, Projected to Hit USD 5.32 Billion by 2028finance.yahoo.com - July 31 at 8:31 AMOpioid Litigants Get Boost From Senate Reportthestreet.com - July 8 at 3:17 PMChronic Fatigue Syndrome Therapeutics Drug Market Till 2030marketwatch.com - May 17 at 1:42 PMPain Management Market Size, Outlook, Trends, Share by 2030marketwatch.com - May 12 at 5:39 AMGlobal Neuropathy Pain Treatment Market [2023] | Industry Set to Expand with Strong 3.4% CAGR and Reach USD 10560 Million by 2030marketwatch.com - May 11 at 1:45 PMHow Turkey's opposition is taking the taboo out of the headscarf debatemsn.com - May 10 at 4:40 PMGlobal Gabapentin Market by Size, Scope 2023: with Development Status 2031marketwatch.com - April 29 at 9:28 AM2023-2030 Chronic Pain Management Drugs Market Size with Manufactures and Upcoming Opportunitiesmarketwatch.com - April 23 at 11:09 PMDepomed, Insys Shares Down After FDA Decision on Endo's Opana ERthestreet.com - April 17 at 5:14 PMPeripheral Neuritis Treatment research report leads towards the developing of this industry with an estimated CAGR 11.1% during 2023-2030marketwatch.com - April 15 at 7:04 PMNeuropathy Pain Treatment Market Growth Prediction and Segment Insight 2023-2107marketwatch.com - April 13 at 9:05 PMNeuropathy Pain Treatment Market 2023 Size and Forecast to 2031marketwatch.com - April 5 at 9:55 AMVulvodynia Treatment Market: Overview of the Regional Outlook 2023-2030marketwatch.com - March 30 at 9:09 AMPain Management Market Size, Growth | Soaring Demand | 2023 - 2029marketwatch.com - March 14 at 12:30 AMPain Relief Medications Market Research Report 2023-2028 with Top Countries Datamarketwatch.com - March 13 at 7:38 AMDiabetic Neuropathy Treatment Market 2023 Exploring New Challenges and Opportunities, Forecast to 2028marketwatch.com - February 21 at 10:00 AMControlled Release Drug Delivery Market 2023 Expected to Reach Significant Rate by 2029marketwatch.com - February 3 at 3:32 AMNeuropathy Pain Treatment Market Growth, Size, Share, Opportunities, Industry Analysis and Forecast 2023 To 2028marketwatch.com - January 29 at 10:51 PMCFO Says Depomed to Buy or Be Soldthestreet.com - January 23 at 1:44 PMNeuropathic Pain Management Market Size, Share and Forecast 2028 with Top Countries Datamarketwatch.com - January 3 at 12:36 PMJ.D. Vance Cancels Fundraiser Planned by Doctor Mentioned in Opioid Lawsuit - Newsweeknewsweek.com - October 15 at 12:33 PMPain Management Drugs Market is Growing Worldwide | 133 Report Pagesmarketwatch.com - October 12 at 8:28 AMNeuropathy Pain Treatment Market Size and Share Research 2022 Key Dynamics, Leading Companies, Business Developments and Demand Forecast 2030marketwatch.com - October 8 at 1:32 AMChronic Fatigue Syndrome Treatment Market Growing Demand and Trends 2022 to 2028 – Pfizer, Teva, Mylanmarketwatch.com - October 4 at 8:00 PMOpioid MDL Attys To Get 'Much More Aggressive' As Talks Lag - Law360law360.com - September 22 at 6:14 AMAssertio Holdings (ASRT) Looks Good To Rebound After Recent Price Plunge - Seeking Alphaseekingalpha.com - September 7 at 5:15 PMREVOLUTION MEDICINES, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.commarketscreener.com - September 1 at 9:47 PMRevolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - Yahoo Financefinance.yahoo.com - September 1 at 9:47 PM(RVMD) – Revolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - Benzingabenzinga.com - September 1 at 4:21 PMRevolution Medicines Strengthens Senior Management Team with Promotions and a New Hire - GlobeNewswireglobenewswire.com - September 1 at 4:21 PMPain Management Therapeutics Market Size Share Volume Trends Demand Forecast Report 2022-2028marketwatch.com - August 20 at 7:11 PMVulvodynia Treatment Market : An Exclusive Study On Upcoming Trends And Growth Opportunities from 2022-2028 | 87 Pages Reportmarketwatch.com - August 19 at 6:07 PMControlled Release Drug Delivery Market Worth USD 91.2 Billion by 2026marketwatch.com - June 10 at 8:57 AMAssertio Holdings, Inc. (ASRT) CEO Daniel Peisert on Q1 2022 Results - Earnings Call Transcript - Seeking Alphaseekingalpha.com - May 10 at 12:07 AMLevi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities Litigationmarkets.businessinsider.com - April 25 at 7:11 PMLevi & Korsinsky, LLP Announces Proposed Settlement of the Depomed (nka Assertio Therapeutics) Securities Litigation - PR Newswireprnewswire.com - April 25 at 2:10 PMGlobal Targeted Drug Delivery Market to Surpass US$ 22,704 Million by 2030, Says Coherent Market Insights (CMI) - Yahoo Financefinance.yahoo.com - April 22 at 11:31 AMDiaCarta Expands Board Leadership with Industry Veteran - PR Newswireprnewswire.com - April 7 at 11:38 AMGlobal Pain Therapeutics Market to 2029 - Featuring Abbott Laboratories, AstraZeneca and GlaxoSmithKline - Benzingabenzinga.com - March 28 at 5:11 PMProtagonist Therapeutics Announces Appointment of Asif Ali as Executive Vice President and Chief Financial Officer - Yahoo Financefinance.yahoo.com - March 28 at 5:11 PMProtagonist Therapeutics Appoints Asif Ali As Executive Vice President And CFO - Nasdaqnasdaq.com - March 28 at 9:11 AMMeet NJ Federal Court's New Magistrate Judge - Law360law360.com - March 23 at 9:00 PMJohnson & Johnson: Your 101 Guide To Litigation Protection - Bankruptcy - Seeking Alphaseekingalpha.com - March 7 at 12:06 PMKetanji Brown Jackson No 'Rubber Stamp' For Gov't Agencies - Law360law360.com - March 3 at 11:55 PMThe Jackson Ruling That Reverberates In Drug Pricing Debate - Law360law360.com - March 1 at 10:58 PMCOLLEGIUM PHARMACEUTICAL, INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) - marketscreener.commarketscreener.com - February 24 at 5:47 PMThe Worldwide Controlled Release Drug Delivery Industry is Expected to Reach $62.26 Million by 2027 - Yahoo Financefinance.yahoo.com - February 24 at 7:44 AM Get Depomed News Delivered to You Automatically Sign up to receive the latest news and ratings for DEPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. DEPO Media Mentions By Week DEPO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DEPO News Sentiment▼0.000.33▲Average Medical News Sentiment DEPO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DEPO Articles This Week▼00▲DEPO Articles Average Week Get Depomed News Delivered to You Automatically Sign up to receive the latest news and ratings for DEPO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CNTX News GRFS News LVTX News MYNZ News NLSP News PHVS News TLSA News ACONW News DRTSW News AONC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DEPO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Depomed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
